It suppresses the high-glucose-enhanced lipolysis response to TNF-α or isoproterenol, reducing free fatty acid concentration and thus improving insulin sensitivity in obese patients and the hyperglycemic conditions of T2DM [69]. The gene discussed is INS; the disease is type 2 diabetes mellitus.